Speakers

View our 25+ expert speakers and discover what novel topics will be covered at the
12th Tumour Models London Summit.

Adam Drake

Head of In Vivo Pharmacology

Ichnos Science

Alex Blyth

Chief Executive Officer

LIFT BIOSCIENCES

Bojan Vilagos

Director - Translational, Research & Development

Exscientia

Clive Roper

Director

ESTIV

Etienne De Braekeleer

Senior Scientist - Cell Biology & Research Immunology

AstraZeneca

Fabien Garcon

Senior Scientist

AstraZeneca

Francesca Barone, MD, PhD

Chief Scientific Officer

Candel Therapeutics

Gabriel van der Pluijm

Associate Professor & Head of Urology Research Laboratory

Leiden University Medical Center

Jonathan Hollick

Managing Director and Head of Research

Breakpoint Therapeutics

Kainat Khan

Associate Director

AstraZeneca

Livija Deban

Chief Scientific Officer

Prokarium

Louis Gall

Senior Scientist

AstraZeneca

Ludovic Waeckel

Grp leader in vivo pharmacology/Head animal Facility

Galapagos NV

Mads Daugaard

President and CSO

Rakovina Therapeutics, Inc.

Marc van Dijk

Chief Scientific Officer

MiNK Therapeutics

Mark Moore

Chief Executive Officer

GemPharmatech

Nicholas Glanville

Vice President Research

Prokarium

Patricia Lucas-Clarke

Early Talent Recruitment Inclusion and Diversity Manager

GSK

Paula Costales Vigil

Senior Scientist - In Vivo Pharmacology

Artios Pharma

Peter Ellmark

Chief Scientific Officer

Alligator Bioscience AB

Rita Fior

Research Associate

Champalimaud Foundation

Rose Ann Padua

Director

Inserm Lille Neuroscience & Cognition research centre

Sumit Kumar

Senior Scientist

AstraZeneca

Tomasz Grabowski

Head, Preclinical Development

JJP Biologics

VIEW THE FULL EVENT GUIDE
SIGN UP HERE